BTAX Projected Dividend Yield
Biostax Corp ( OTCBB : BTAX )Biostax Corp. develops and markets pharmaceutical, biotechnology, and MedTech products, focusing on autoimmunity and immune restoration. It offers solutions for autoimmunity, chronic inflammation, infection, and cancer. Key programs include JKB-122, a TLR4 antagonist for autoimmune hepatitis, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis with anti-fibrotic and anti-inflammatory effects; Lodonal, an immune system regulator for human immunodeficiency virus and acquired immune deficiency syndrome; and LDN, a compound with purported immune-modulating benefits for cancer, pain, autoimmunity, and anti-aging. 21 YEAR PERFORMANCE RESULTS |
BTAX Dividend History Detail BTAX Dividend News BTAX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |